Biogen Inc. (LON:0R1B)
London · Delayed Price · Currency is GBP · Price in USD 195.52
+4.97 (2.61%)
Feb 12, 2026, 4:59 PM GMT
Biogen Market Cap
Biogen has a market cap or net worth of 20.57 billion as of February 12, 2026. Its market cap has increased by 20.64% in one year.
Market Cap
20.57B
Enterprise Value
22.33B
Revenue
7.35B
Ranking
n/a
PE Ratio
21.41
Stock Price
195.52
Market Cap Chart
Since September 17, 1991, Biogen's market cap has increased from 89.21M to 20.57B, an increase of 22,953.93%. That is a compound annual growth rate of 17.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 20.57B | 7.21% |
| Dec 31, 2025 | 19.18B | 7.77% |
| Dec 31, 2024 | 17.80B | -39.53% |
| Dec 29, 2023 | 29.44B | -11.06% |
| Dec 30, 2022 | 33.10B | 27.16% |
| Dec 31, 2021 | 26.03B | -5.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.40B |
| GSK plc | 86.64B |
| Haleon | 35.66B |
| Smith & Nephew | 10.82B |
| Convatec Group | 4.41B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.82B |